Actively Recruiting
A Group-based Treatment for Self-stigma in People With Mental Disorders in North-east Italy
Led by Universita di Verona · Updated on 2024-11-26
416
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Self-stigma refers to the internalization of negative stereotypes by individuals with mental disorders, leading to beliefs that they are dangerous, aggressive, or incapable of working. This phenomenon has harmful effects on various aspects of life, such as adherence to treatment, self-esteem, quality of life, and can increase feelings of despair and suicide risk. To address these issues, the Narrative Enhancement and Cognitive Therapy (NECT) was developed. NECT is a group-based intervention consisting of 20 sessions designed to reduce self-stigma in individuals with mental disorders. This study aims to evaluate the efficacy and feasibility of NECT in 416 patients from 26 mental health centers in Northeast Italy. It is structured as a pragmatic, multicenter, randomized controlled trial with two parallel arms. The study will assess the impact of NECT on several psychological dimensions, including levels of self-stigma, self-esteem, hope, empowerment, perception of recovery, mental well-being, and stigma-related stress. The findings of this research are expected to contribute to the understanding of effective treatments for patients with mental disorders, particularly those burdened by high levels of self-stigma, and to improve their recovery outcomes.
CONDITIONS
Official Title
A Group-based Treatment for Self-stigma in People With Mental Disorders in North-east Italy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be 18 years or older.
- Diagnosed with schizophrenia, schizoaffective disorder, schizoid disorder, schizophreniform disorder, bipolar I or II disorder, or major depressive disorder according to DSM-5.
- Outpatients with clinical stability for at least 3 months and no pharmacological treatment changes during this period.
- Sufficient knowledge of written and spoken Italian.
- Score above 1 on the Internalized Stigma of Mental Illness (ISMI) scale indicating moderate self-stigma or higher.
You will not qualify if you...
- Unable to provide informed consent.
- Have intellectual disabilities.
- Primary diagnosis of personality disorder or substance dependence.
- Currently participating in other programs that could influence self-stigma, such as social cognitive rehabilitation or social skills training.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Azienda Ospedaliera Universitaria Integrata (AOUI) Verona
Verona, Italy, 37134
Actively Recruiting
Research Team
A
Antonio Lasalvia, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here